Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706121 · ClinicalTrials.gov registry record · Phase 3
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
A Phase 3 study, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 8,094
- Enrollment target
NCT00706121 is a Phase 3 study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 8,094 participants.
The verdict
NCT00706121, a Phase 3 study, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 8,094 participants
- Enrollment target
Study Summary
RATIONALE: Studying tissue samples in the laboratory from participants receiving treatment on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000 may help doctors predict a participant's response to treatment and help plan the best treatment. PURPOSE: This phase III trial is studying the effect of vitamin E and/or selenium on colorectal polyps in men enrolled on SELECT Trial SWOG-S0000.
Interventions
- DRUG Vitamin E
- DRUG Selenium
- DRUG selenium placebo
- DRUG Vitamin E placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,094 participants |
| Start Date | 2008-06 |
| Est. Completion | 2018-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706121
The ClinicalTrials.gov registry entry for NCT00706121 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 8,094 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vitamin E is the first listed.
NCT00706121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706121 about?
NCT00706121 is a clinical study titled "S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000". RATIONALE: Studying tissue samples in the laboratory from participants receiving treatment on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000 may help doctors predict a participant's response to treatment and help plan the best treatment. PURPOSE: This phase III trial is stud...
What is the current status of trial NCT00706121?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 8,094 participants. The study started on 2008-06. Estimated completion is 2018-01.
What interventions are being tested in trial NCT00706121?
The interventions under investigation include: Vitamin E (DRUG), Selenium (DRUG), selenium placebo (DRUG), Vitamin E placebo (DRUG).
Who is sponsoring clinical trial NCT00706121?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.